batifiban

synthetic peptide; structure in first source

Also Known As:

N5-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-arginylglycyl-L-alpha-aspartyl-L-alpha-trypotophyl-L-alpha-prolyl-L-alpha-cysteinamide,cyclic(1-6)-disulfide

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - batifiban: 2
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - batifiban: 2

Experts

1.	Chen, Hui: 2 articles (10/2013 - 02/2009)
2.	Chen, Ke: 1 article (10/2013)
3.	He, Xiao-Meng: 1 article (10/2013)
4.	Jia, Meng-Meng: 1 article (10/2013)
5.	Li, Jie: 1 article (10/2013)
6.	Li, Sheng-Feng: 1 article (10/2013)
7.	Li, Wei-Yong: 1 article (10/2013)
8.	Liu, Ming-Zhou: 1 article (10/2013)
9.	Wang, Yao-Hua: 1 article (10/2013)
10.	Wu, San-Lan: 1 article (10/2013)

Related Diseases

Acute Coronary Syndrome

02/01/2009 - "These results support a bolus injection plus intravenous infusion regimen of batifiban for the treatment and prevention of acute coronary syndromes."
10/01/2013 - "The combined use of batifiban, a synthetic platelet GPII b/ IIIa receptor antagonist, and antithrombin agents is an attractive option for the treatment of patients with non-ST-segment elevation (NSTE) acute coronary syndrome (ACS) and those scheduled for percutaneous coronary intervention. "
02/01/2009 - "Batifiban, a synthetic cyclic peptide, is a potent platelet glycoprotein GPIIb/IIIa antagonist which may be useful in the treatment and prevention of acute coronary syndromes. "

Related Drugs and Biologics

1.	Platelet Membrane Glycoproteins
2.	Cyclic Peptides
3.	Antithrombins

Related Therapies and Procedures

1.	Percutaneous Coronary Intervention
2.	Intravenous Infusions